Immunomedics Inc. (IMMU) belonging to the Healthcare sector has declined -19.35% and closed its last trading session at $10.
The company reported its EPS on 9/29/2017. Currently, the stock has a 1 Year Price Target of $14.17.
The consensus recommendation, according to Zacks Investment research, is 1. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell.
The Stock had a 1 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 1 and 1 respectively.
Immunomedics Inc. on 9/29/2017 reported its EPS as $-0.23 with the analysts projecting the EPS of the stock as $-0.13. The company beat the analyst EPS Estimate with the difference of $-0.1. This shows a surprise factor of -0.769%.
Many analysts have provided their estimated foresights on Immunomedics Inc. Earnings, with 3 analysts believing the company would generate an Average Estimate of $-0.12.
Whereas they predicted High and Low Earnings Estimate as $-0.06 and $-0.16 respectively. While in the same Quarter Previous year, the Actual EPS was $-0.23.
Analysts are also projecting an Average Revenue Estimate for Immunomedics Inc. as $4730 in the Current Quarter. This estimate is provided by 3 analysts.
The High Revenue estimate is predicted as 12700, while the Low Revenue Estimate prediction stands at 600000. The company’s last year sales total was 384000.
For the Current Quarter, the growth estimate for Immunomedics Inc. is 47.8%, while for the Next Quarter the stock growth estimate is 76.4%.
Insider Trades for Immunomedics Inc. show that the latest trade was made on 31 Aug 2017 where Goldenberg (David M), the Officer and Director completed a transaction type “Sell” in which 10000 shares were traded at a price of $12.9.
Immunomedics Inc. (IMMU) has the market capitalization of $1.06 Billion. The company rocked its 52-Week High of $14.48 and touched its 52-Week Low of $2.51.
The stock has Return on Assets (ROA) of -150 percent. Return on Equity (ROE) stands at 137.7% and Return on Investment (ROI) of -200.9 percent.
The stock is currently showing YTD performance of 172.48 Percent. The company has Beta Value of 1.51 and ATR value of 1.04. The Weekly and Monthly Volatility stands at 11.84% and 8.60%.